What's new

Human medicines European public assessment report (EPAR): Kavigale, sipavibart, Date of authorisation: 20/01/2025, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Kavigale, sipavibart, Date of authorisation: 20/01/2025, Revision: 1, Status: Authorised

May 5, 2025 - 15:09
 0
Human medicines European public assessment report (EPAR): Kavigale, sipavibart, Date of authorisation: 20/01/2025, Revision: 1, Status: Authorised
Human medicines European public assessment report (EPAR): Kavigale, sipavibart, Date of authorisation: 20/01/2025, Revision: 1, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Circadin, melatonin, D...

Next Article

Human medicines European public assessment report (EPAR): mResvia, Single-strand...

Related Posts

Business process description for regulatory and scienti...

Apr 22, 2025  0

Human medicines European public assessment report (EPAR): Vyvgart, efgartigimod alfa, Date of authorisation: 10/08/2022, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 30, 2025  0

FertiPro N.V. HSA-containing ART media - Procedural ste...

Apr 24, 2025  0